| Bioactivity | 1-Amino-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl) guanine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 1-Amino-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl) guanine |
| CAS | 2389988-21-8 |
| Formula | C10H14N6O6 |
| Molar Mass | 314.25 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
1-Amino-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl) guanine
CAS: 2389988-21-8 F: C10H14N6O6 W: 314.25
1-Amino-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl) guanine is a purine nucleoside analogue. Purine nucleoside analogs have
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.